Search results
Amgen is a biotech company that develops and delivers innovative medicines for serious illnesses. Learn about its latest news, stories, science, leadership, and social responsibility.
- Careers
Amgen is an Equal Opportunity Employer and will consider all...
- Products
Our Products. Amgen’s medicines treat serious illnesses and...
- Contact Us
To report a legal, ethical or compliance concern regarding...
- About
Amgen helped establish the biotechnology industry more than...
- Leadership
At Amgen, we recognize that innovation comes from many...
- Careers
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000 (8.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura ...
- April 8, 1980; 43 years ago
- Thousand Oaks, California, U.S.
- c. 25,200 (December 2022)
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla ...
People also ask
Is Amgen a biotechnology company?
What makes Amgen unique?
Does Amgen treat serious illnesses?
What does Amgen do?
Amgen Biosimilars are backed by our four decades of experience in the research, development, manufacturing, and supply of innovator biologics. Amgen Business Development Amgen’s business development team brings together deep scientific, financial, deal, partnership, and integration expertise—along with an ability to bring the right people ...
Jan 31, 2023 · AMJEVITA is a citrate-free anti-TNF-α monoclonal antibody that has the same amino acid sequence as Humira. It is approved to treat seven inflammatory diseases and is offered at a list price 55% or 5% below Humira.
Feb 26, 2024 · Amgen opened a cutting-edge facility in Central Ohio on February 26, 2024, to produce innovative biomedicines for seriously ill patients. The site is part of Amgen's global network and will create 400 local jobs and $40 million in annual payroll.
